Global Epidemiology and Burden of Elderly-Onset Inflammatory Bowel Disease: A Decade in Review.
Crohn’s disease
geriatric
inflammatory bowel disease
ulcerative colitis
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
06 Aug 2023
06 Aug 2023
Historique:
received:
09
06
2023
revised:
28
07
2023
accepted:
03
08
2023
medline:
12
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
Inflammatory bowel disease (IBD), once thought to impact younger individuals, now manifests in approximately 10% of patients over 65, characterized by a heightened vulnerability to complications and greater diagnostic intricacies than conventional cases. However, comprehensive global epidemiological data regarding elderly-onset IBD are currently insufficient. Our study addresses this critical gap by analyzing trends in elderly-onset IBD over a decade, encompassing the estimation of annual frequencies and age-standardized rates of elderly-onset IBD burden for both genders, stratifying the data by geographical and sociodemographic factors. Our research highlights a notable increase in the proportion of elderly-onset IBD, constituting around 13% of all IBD cases. We observed a rising incidence in males, contrasted by a decreasing trend in females. The highest surge in incidence rates was seen in the Western Pacific region in both genders, but the highest burden was observed in America. Countries with high sociodemographic index (SDI) carried the greatest burden of elderly-onset IBD, while countries with low SDI had the least. The mortality and disability-adjusted life years (DALYs) rates trend downward in most regions. This study underscores an increasing incidence and proportion of IBD, particularly in elderly-onset IBD, particularly in males. While mortality and DALYs are decreasing in most regions, the overall burden remains highest in America and high-SDI countries. Effective public health interventions and comprehensive studies are required to tackle this mounting burden.
Identifiants
pubmed: 37568544
pii: jcm12155142
doi: 10.3390/jcm12155142
pmc: PMC10420121
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Can J Gastroenterol. 2012 Nov;26(11):811-7
pubmed: 23166905
Drugs Aging. 2017 Nov;34(11):859-868
pubmed: 29170864
BMJ Open. 2023 Mar 28;13(3):e065186
pubmed: 36977543
J Crohns Colitis. 2023 May 3;17(5):706-711
pubmed: 36420953
J Inflamm Res. 2014 Jun 23;7:113-20
pubmed: 25075198
World J Gastroenterol. 2011 Jun 14;17(22):2734-9
pubmed: 21734781
Gastroenterology. 2019 Apr;156(5):1345-1353.e4
pubmed: 30639677
Lancet. 2018 Dec 23;390(10114):2769-2778
pubmed: 29050646
Nat Rev Gastroenterol Hepatol. 2018 Jul;15(7):440-452
pubmed: 29670252
Curr Gastroenterol Rep. 2019 Jul 23;21(8):40
pubmed: 31338613
Inflamm Bowel Dis. 2009 Feb;15(2):182-9
pubmed: 18668678
Curr Treat Options Gastroenterol. 2018 Sep;16(3):289-305
pubmed: 30006766
Gastroenterology. 2019 Jan;156(1):254-272.e11
pubmed: 30315778
Acta Gastroenterol Belg. 2001 Apr-Jun;64(2):197-200
pubmed: 11475135
J Crohns Colitis. 2015 Jun;9(6):507-15
pubmed: 25870198
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):720-7
pubmed: 26323879
Gastroenterology. 2022 Dec;163(6):1547-1554.e5
pubmed: 35952799
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S1-S5
pubmed: 31294380
Gastroenterology. 1998 Jun;114(6):1161-8
pubmed: 9609752
Inflamm Bowel Dis. 2011 Aug;17(8):1792-9
pubmed: 21744435
Surg Clin North Am. 2019 Dec;99(6):1051-1062
pubmed: 31676047
Intest Res. 2023 Apr;21(2):216-225
pubmed: 35929090
World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):51-65
pubmed: 26855812